Navigation Links
Cloned receptor paves way for new breast and prostate cancer treatment
Date:9/13/2012

Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells. The study is being published this week in PNAS.

Genetically modified T cells (white blood corpuscles) have recently been shown to be extremely effective in treating certain forms of advanced cancer. T cells from the patient's own blood cells are isolated and equipped by genetic means with a new receptor that recognizes an antigen that is expressed in the tumour cells. These T cells are cultivated in a special clean room and then administered to the patient. Once inside the body, they seek out sub tumours and individual tumour cells and eliminate them.

This form of treatment attracted major attention in the world media last autumn when researchers at the University of Pennsylvania, Philadelphia, managed to cure two of three patients with an otherwise incurable form of leukaemia (Kalos et al., Sci Transl Med 3:95ra73, 2011; Porter et al., N Engl J Med 365:725-33, 2011). Trials with genetically modified T-cells have also met with some success in treating malignant melanoma at the National Cancer Institute in Bethesda (Morgan et al., Science 314:126-9, 2006).

Magnus Essand's research team at Uppsala University has now taken the first steps towards making this highly promising form of therapy feasible also for the major public health diseases prostate cancer and breast cancer.

"This is definitely a step along the way to a form of therapy also for our two largest cancer types (prostate cancer and breast cancer)."

Genetically modified T cells are one of two promising avenues the research team is pursuing in order to develop new treatments for cancer. It has taken nearly three years for the scientists to clone the T-ce
'/>"/>

Contact: Professor Magnus Essand
magnus.essand@igp.uu.se
46-018-611-0223
Uppsala University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Eliminating the good cholesterol receptor may fight breast cancer
2. Breast stem-cell research: Receptor teamwork is required and a new pathway may be involved
3. Opioid receptors as a drug target for stopping obesity
4. H1N1 discovery paves way for universal flu vaccine: UBC research
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. Researchers develop a new cell and animal model of inflammatory breast cancer
7. Scientists uncover multiple faces of deadly breast cancer
8. Depo-Provera Birth Control Might Raise Breast Cancer Risk
9. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
10. Mayo Clinic launches whole genome breast cancer study
11. Breast cancer patients suffer treatment-related side effects long after completing care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (Boston)-- Researchers from Boston University School of Medicine ... that participants who received care through BMC,s Violence ... physical, mental, emotional and social needs of violently ... injuries and experienced life changing behaviors through connections ... feel trust and hope. These findings are reported ...
(Date:7/22/2014)... The European Bio stimulants Market report defines ... analysis and forecast of revenue. The bio stimulants market ... million in 2013 to $940.6 million by 2018, at ... Browse through the TOC of the Europe Bio stimulants ... analysis provided. , http://www.micromarketmonitor.com/market/europe-bio-stimulants-1315565884.html , Agriculture contributes ...
(Date:7/22/2014)... California (PRWEB) July 22, 2014 In ... women in recovery, the Marinello School of Beauty joined ... Addiction Treatment Center for a free “Make-over Day.” ... to be of service to the community, and The ... and renewed. They also gained some first-hand experience about ...
(Date:7/22/2014)... 2014 Expert Publishing ... , announces the launch of PoisonEXPERT™ , ... safety professionals employed by organizations that use or ... manage the impact of chemicals on their employees ... relevant chemical-specific information and medical protocols that allows ...
(Date:7/22/2014)... Transparency Market Research has announced the ... Diagnostics Market – Global Industry Analysis, Size, Share, Growth, ... comprehensive database. This industry is considered as the most ... valued at USD 8.7 billion by 2019 and expected ... to 2019. Molecular diagnostics is the class of diagnostic ...
Breaking Medicine News(10 mins):Health News:Clients of BMC's violence interventional advocacy program find experience supportive 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:The Discovery House 'Make-over Day' Adds Pampering To Recovery 2Health News:The Discovery House 'Make-over Day' Adds Pampering To Recovery 3Health News:PoisonEXPERT™ from ExPub Now Available 2Health News:PoisonEXPERT™ from ExPub Now Available 3Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 2Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 3Health News:Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research 4
... a Diet High in Fruits and Vegetables ,Healthy Foods ... patients with kidney disease, the Western diet produces an acidic ... worsens with age as kidney function declines. Nimirit Goraya, MD ... and her colleagues conducted a study to see if consuming ...
... By Ellin Holohan HealthDay Reporter , FRIDAY, ... against alcohol use, can relax and have a drink a ... weight, two new Dutch studies show. The researchers found ... be unfounded, while concerns about weight are not. Both ...
... 19 (HealthDay News) -- A new, small study suggests that the ... dose of tamoxifen, a drug commonly used to prevent and treat ... cough medicine at about the same rate as tamoxifen, allowing doctors ... drug. "This study is starting to identify a personalized ...
... NEW YORK (Nov. 20, 2010) Columbia University Medical ... a Harvard researcher who has made important advances in ... and heart disease. A promising young investigator at Columbia ... the basis for disordered lipid metabolism in diabetes. ...
... By Madonna Behen HealthDay Reporter , FRIDAY, Nov. ... on U.S. college campuses, college officials are trying various ways ... targeted off-campus boozing shows some promise, researchers say. ... cut the level of heavy drinking at private parties and ...
... 19, 2010 University of Houston (UH) physicists are ... a crucial protein that, when malfunctioning, may cause Alzheimer,s ... physics at UH, and Antonios Samiotakis, a physics Ph.D. ... function, and folding of phosphoglycerate kinase (PGK) are strongly ...
Cached Medicine News:Health News:Kidneys: Produce-rich diet improves long-term health, melatonin improves short-term health 2Health News:Kidneys: Produce-rich diet improves long-term health, melatonin improves short-term health 3Health News:Moderate Drinking Could Lower Death Risk for Kidney Transplant Patients 2Health News:Moderate Drinking Could Lower Death Risk for Kidney Transplant Patients 3Health News:Moderate Drinking Could Lower Death Risk for Kidney Transplant Patients 4Health News:Cough Syrup Might Help With Dosing of Breast Cancer Drug 2Health News:Harvard expert on inflammation's role in obesity receives Columbia's 2010 Naomi Berrie Award 2Health News:Harvard expert on inflammation's role in obesity receives Columbia's 2010 Naomi Berrie Award 3Health News:Harvard expert on inflammation's role in obesity receives Columbia's 2010 Naomi Berrie Award 4Health News:Outreach, Enforcement Can Curb College Kids' Drinking: Study 2Health News:Outreach, Enforcement Can Curb College Kids' Drinking: Study 3Health News:UH physicists study behavior of enzyme linked to Alzheimer's, cancer 2Health News:UH physicists study behavior of enzyme linked to Alzheimer's, cancer 3
(Date:7/22/2014)... , July 22, 2014 Sanofi Pasteur, the ... SNY ), announced today that the first lots of Fluzone ... season have been released by the U.S. Food and Drug ... 21, 2014, representing the first of at least 65 million ... will be delivered to U.S. health care providers and pharmacies ...
(Date:7/22/2014)... Israel , July 22, 2014 Galmed ... clinical-stage biopharmaceutical company focused on the development and commercialization ... liver diseases and cholesterol gallstones, announced today that the ... Galmed,s Investigational New Drug, or IND, application.  Such clearance ... product candidate, aramchol, in the United States ...
(Date:7/22/2014)... -- Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. (OTCQB: ... the Icahn School of Medicine at Mount ... to utilize its proprietary information and data package for ... Type C Disease (NPC), a rare disease, mostly of ... also covers other diseases and disorders relying on activation ...
Breaking Medicine Technology:Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 2Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 3Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
... N.J., June 24, 2011 Laureate Biopharmaceutical Services, ... Drug Administration ("FDA") approved its application for an ... gateway will allow Laureate to offer clients a ... Drug), NDA (New Drug Application) and BLA (Biologic ...
... June 24, 2011 Elekta,s Leksell Gamma Knife® Perfexion™ earned ... released 2011 Top 20 Best in KLAS Awards: Medical ... in the radiation therapy category. In the ... of customers indicated they would buy again. On a 1 ...
Cached Medicine Technology:Laureate's Electronic Submission Gateway Approved 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 3